Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

3.8K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.8K
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

751
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
751
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

1.3K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.3K
Hormonal Regulation01:33

Hormonal Regulation

36.6K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
36.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

7.6K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.6K
Hypoxia01:23

Hypoxia

2.4K
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
2.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The hypothalamic-neurohypophyseal system in preeclampsia: a systematic review with a subgroup meta-analysis of copeptin levels worldwide.

Frontiers in endocrinology·2026
Same author

Luteolin decreases sFlt-1 and mean arterial pressure in the RUPP animal model of placental ischemia.

Placenta·2026
Same author

Severe preeclampsia: immediate action as a strategy to save lives.

Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia·2025
Same author

Problem-based learning in obstetrics and gynecology: a systematic review.

Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia·2025
Same author

Paliperidone as an Alternative Treatment for Behavioral Symptoms in Childhood Autism: Case Report of an Eight-Year-Old Patient.

Cureus·2025
Same author

Cytotoxicity and induction of proinflammatory cytokines in placental explant cells following azathioprine exposure.

Placenta·2025

Related Experiment Video

Updated: Mar 9, 2026

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
05:31

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles

Published on: January 26, 2024

1.4K

Relationship between hypoxia and downstream pathogenic pathways in preeclampsia.

Henri Augusto Korkes1,2, Leandro De Oliveira2, Nelson Sass2

  • 1a Departments of Medicine, Obstetrics and Gynecology, Beth Israel Deaconess Medical Center , Harvard Medical School , Boston , Massachusetts , USA.

Hypertension in Pregnancy
|January 10, 2017
PubMed
Summary

Preeclampsia involves placental defects. This study found that while hypoxia-inducible factor-1α (HIF-1α) was upregulated, it did not correlate with anti-angiogenic factors or microRNA 210, suggesting non-hypoxia pathways in preeclampsia.

Keywords:
HIF-1α proteinmiR-210placentapreeclampsiapregnancysFlt1

More Related Videos

Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
12:02

Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption

Published on: July 30, 2016

16.6K
Hypoxia Alters miRNAs Levels Involved in Non-Mendelian Inheritance of Autism Spectrum Disorder in Mice
09:13

Hypoxia Alters miRNAs Levels Involved in Non-Mendelian Inheritance of Autism Spectrum Disorder in Mice

Published on: July 11, 2025

33.5K

Related Experiment Videos

Last Updated: Mar 9, 2026

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
05:31

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles

Published on: January 26, 2024

1.4K
Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
12:02

Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption

Published on: July 30, 2016

16.6K
Hypoxia Alters miRNAs Levels Involved in Non-Mendelian Inheritance of Autism Spectrum Disorder in Mice
09:13

Hypoxia Alters miRNAs Levels Involved in Non-Mendelian Inheritance of Autism Spectrum Disorder in Mice

Published on: July 11, 2025

33.5K

Area of Science:

  • Obstetrics and Gynecology
  • Molecular Biology
  • Pathophysiology

Background:

  • Preeclampsia pathogenesis involves placental angiogenesis and mitochondrial dysfunction.
  • Placental hypoxia, potentially from abnormal spiral artery remodeling, is implicated in these defects.
  • Upstream regulators of these pathways in preeclampsia remain largely unknown.

Purpose of the Study:

  • To investigate the relationship between hypoxia-inducible factor-1α (HIF-1α), soluble fms-tyrosine kinase 1 (sFlt1), and microRNA 210 (miR-210) in preeclamptic placentas.
  • To assess HIF-1α as a surrogate for hypoxia and its association with angiogenic and mitochondrial dysfunction markers.
  • To explore potential non-hypoxia driven mechanisms in preeclampsia.

Main Methods:

  • Quantification of HIF-1α protein, sFlt1 mRNA, and miR-210 levels in human placentas from preeclamptic and non-hypertensive pregnancies.
  • Statistical analysis to determine correlations between HIF-1α, sFlt1, and miR-210 expression.
  • Utilized quantitative polymerase chain reaction (qPCR) and Western blotting techniques.

Main Results:

  • Confirmed a 2.5-fold increase in HIF-1α protein in preeclamptic placentas compared to controls.
  • Observed a 10-fold upregulation of sFlt1 mRNA and a 2-fold increase in miR-210 in preeclamptic tissues.
  • Found a significant correlation between sFlt1 mRNA and miR-210 (R² = 0.77, p = 0.0004) but no significant correlation with HIF-1α.

Conclusions:

  • The study suggests that while HIF-1α is upregulated in preeclampsia, it may not be the primary driver for sFlt1 and miR-210 alterations.
  • Non-hypoxia-related pathways might play a significant role in the angiogenic and metabolic dysregulation observed in preeclampsia.
  • Further research is needed to elucidate the upstream regulators involved in preeclampsia pathophysiology.